The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA
Conditions: Severe Aplastic Anemia Interventions: Drug: Busulfan; Drug: Flu/Cy/ATG or Cy/ATG Sponsors: Peking University People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Cyclophosphamide Added to Standard Immunosuppressive Therapy With Eltrombopag as Front-line Therapy in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia Intervention: Drug: Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients With Aplastic Anemia
Conditions: Aplastic Anemia; Platelet Transfusion Refractoriness Intervention: Drug: Daratumumab Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials